BOZZINI, Claudia
 Distribuzione geografica
Continente #
NA - Nord America 1.575
EU - Europa 1.187
AS - Asia 301
OC - Oceania 4
SA - Sud America 3
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.072
Nazione #
US - Stati Uniti d'America 1.570
GB - Regno Unito 542
CN - Cina 263
SE - Svezia 147
FR - Francia 117
IE - Irlanda 104
FI - Finlandia 102
DE - Germania 65
IT - Italia 55
UA - Ucraina 26
TR - Turchia 13
KR - Corea 12
BE - Belgio 11
IN - India 8
RU - Federazione Russa 8
NL - Olanda 4
CA - Canada 3
AL - Albania 2
AU - Australia 2
BR - Brasile 2
IL - Israele 2
MX - Messico 2
NZ - Nuova Zelanda 2
AT - Austria 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
CL - Cile 1
EG - Egitto 1
EU - Europa 1
LU - Lussemburgo 1
LV - Lettonia 1
SA - Arabia Saudita 1
SG - Singapore 1
Totale 3.072
Città #
Southend 477
Jacksonville 340
Chandler 287
Woodbridge 181
Ann Arbor 161
Houston 109
Dublin 104
Ashburn 58
New York 50
Lawrence 41
Princeton 41
Lancaster 39
Nanjing 35
Wilmington 34
Helsinki 27
Jinan 23
Shenyang 20
Tianjin 20
Beijing 18
Hebei 14
Milan 14
Nanchang 14
Zhengzhou 14
Jiaxing 12
Seoul 12
Sindelfingen 12
Brussels 11
Changsha 11
Norwalk 10
Hangzhou 9
Seattle 9
Fuzhou 8
Taiyuan 7
Boardman 6
Guangzhou 6
Lanzhou 6
Mestre 6
Verona 6
Haikou 5
Ningbo 5
Cagliari 4
Dongguan 4
Kochi 4
Perugia 4
San Francisco 4
San Mateo 4
Washington 4
Clearwater 3
Fairfield 3
Rome 3
Toronto 3
Augusta 2
Bangalore 2
Boston 2
Chaoyang 2
Dearborn 2
Düsseldorf 2
Latina 2
Messina 2
Mexico City 2
Naples 2
San Diego 2
São Paulo 2
Taizhou 2
Tirana 2
Amsterdam 1
Auckland 1
Baku 1
Berlin 1
Cairo 1
Canberra 1
Changle 1
Des Moines 1
Hamilton 1
Hanover 1
Kansas City 1
Kemerovo 1
Leawood 1
Los Angeles 1
Luxembourg 1
Mehlingen 1
Melbourne 1
Miami 1
Mumbai 1
Orlando 1
Phoenix 1
Redmond 1
Riva 1
Riyadh 1
Sarajevo 1
Secaucus 1
Singapore 1
Tottenham 1
Vienna 1
Totale 2.359
Nome #
Novel serum paraoxonase activity assays are associated with coronary artery disease 128
Interaction between metabolic syndrome and PON 1 polymorphism as a determinant of the risk of coronary artery disease 103
Interaction between folate and MTHFR1298 A/C polymorphism on Genomic DNA Methylation 101
Clinical heterogeneity of acquired hemophilia A: a description of 4 cases. 98
Clinical and pathological findings in hemochromatosis type 3 due to a novel mutation in transferin receptor 2 gene 97
Hyperhomocysteinemia and mortality after coronary artery by-pass grafing. 96
Combined effect of hemostatic gene polymorphisms and the risk of myocardial infarction in patients with advanced coronary atherosclerosis. 95
Hyperhomocysteinemia and Mortality after Coronary Artery Bypass Grafting 93
Low plasma vitamin B-6 concentrations and modulation of coronary artery disease risk. 92
Prevalence of hereditary hyperferritinemia-catarat siyndrome in blood donors and in patients with cataract 84
Low circulating vitamin B6 markers of inflammation, and risk of coronary artery disease. 84
High levels of homocysteine are associated with small number of traditional cardiovascular risk factors in patients with similar degree of coronary atherosclerosis. 84
Polymorphisms in the Hemostatic Pathway Genes and the Risk of Myocardial infarction in Patients with Advanced Coronary Artery Disease. Results from the Verona Heart Project. 84
Prevalence of body iron excess in the metabolic syndrome. 82
Factor VIII:c Levels in Subjects with the Factor V R2 Polymorphism. 81
Clinical, pathological, and molecular correlates in ferroportin disease: a study of two novel mutations. 78
Clinical,biochemical and molecular findings in a series of families with hereditary hyperferritinemia cataract syndrome 77
Low vitamin B6, markers of inflammation, and risk of coronary artery disease. 77
BIOCHEMICAL AND GENETIC MARKERS OF IRON STATUS AND RISK OF CORONARY ARTERY DISEASE: AN ANGIOGRAPHIC-BASED STUDY. 76
Determinants of serum ferritin in the metabolic syndrome. 76
Biochemical and genetic markers of iron status and the risk of coronary disease 74
Determinants of serum ferritin and prevalence of iron overload in the Metabolic (Insulin Resistance). 70
Interaction between PON 2 polymorphism Ser-Cys and smoking as a determinant of myocardial infarction risk 69
A new mutation in the trnsferrin receptor 2 gene in hemochromatosis type 3 69
CLINICAL AND HISTOPATHOLOGICAL FINDINGS IN A FAMILY WITH HEMOCROMATOSIS TYPE 3, CARRING A NEW MUTATION IN TRANSFERRIN RECEPTOR 2 GENE 68
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis. 68
A new mutation in transferrin receptor 2 gene in hemochromatosis type 3 67
Influence of the polymorphism in the factor VII gene promoter on Factor VII circulating levels and on the risk of myocardial infarction in advanced coronary atherosclerosis 65
Molecular pathology of hereditary hemochromatosis 65
Increase arachidonic/linoleic acid ratio and a polygenic model of desaturases polymorphism are associated with increase risk of coronary artery disease 64
Factor VII polymorphisms and the risk of myocardial infarction in coronary atherosclerosis. 64
Factor VII polymorphisms and the risk of myocardial infarction in coronary atherosclerosis. 63
Two new highly polymorphic markers in the 3’UTR region of the PLA2G7 gene 62
Met-Leu and Gln-Arg PON 1 polymorphisms and mortality after coronary artery by-pass grafing surgery. 60
Blunted hepcidin response to oral iron challenge in BFE-related hemochromatosis 59
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis 58
Polymorphism in the factor VII gene promoter (-323°1°2 and -402 GA) and the risk of myocardial infarction in patients with advance coronary atherosclerosis 53
Measurament of urinary hepcidin levels by self-tof-ms in HFE-hemochromatosis 51
Prevalence of hereditary hyperferritinemia-cataract syndrome in blood donors and in patients with cataract. 50
Interaction between metabolic syndrome and PON1 polymorphisms as a determinant of the risk of coronary artery disease 44
Influence of polymorphisms in the factor VII gene promoter on activated factor VII levels and on the risk of myocardial infarction in advanced coronary atherosclerosis 28
Red Blood Cell Morphologic Abnormalities in Patients Hospitalized for COVID-19 28
Totale 3.085
Categoria #
all - tutte 8.606
article - articoli 4.010
book - libri 0
conference - conferenze 4.397
curatela - curatele 0
other - altro 199
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.212


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201916 0 0 0 0 0 0 0 0 0 0 3 13
2019/2020390 59 3 2 42 31 62 46 40 14 44 8 39
2020/2021361 33 66 18 40 35 40 5 44 40 2 37 1
2021/2022296 26 70 3 33 18 9 4 18 6 13 28 68
2022/2023803 47 84 74 143 97 179 5 36 95 10 15 18
2023/2024293 8 29 27 44 42 77 9 34 5 18 0 0
Totale 3.085